Xenobiotica
Basic Information
Xenobiotica is a subscription-based, peer-reviewed journal that covers seven main areas, including: General Xenobiochemistry, including in vitro studies concerned with the metabolism, disposition and excretion of drugs, and other xenobiotics, as well as the structure, function and regulation of associated enzymes Clinical Pharmacokinetics and Metabolism, covering the pharmacokinetics and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in man Animal Pharmacokinetics and Metabolism, covering the pharmacokinetics, and absorption, distribution, metabolism and excretion of drugs and other xenobiotics in animals Pharmacogenetics, defined as the identification and functional characterisation of polymorphic genes that encode xenobiotic metabolising enzymes and transporters that may result in altered enzymatic, cellular and clinical responses to xenobiotics Molecular Toxicology, concerning the mechanisms of toxicity and the study of toxicology of xenobiotics at the molecular level Xenobiotic Transporters, concerned with all aspects of the carrier proteins involved in the movement of xenobiotics into and out of cells, and their impact on pharmacokinetic behaviour in animals and man Topics in Xenobiochemistry, in the form of reviews and commentaries are primarily intended to be a critical analysis of the issue, wherein the author offers opinions on the relevance of data or of a particular experimental approach or methodology. The journal’s audience includes pharmacokineticists, toxicologists, biochemists, pharmacologists and chemists. A close liaison between Xenobiotica and the International Society for the Study of Xenobiotics has been established, giving rise to special issues of the journal. The journal welcomes for consideration the following types of article: research articles, reviews, data notes and short communications. All articles received by the Journal will be subject to double-anonymous peer review.
CiteScore
| Subject | Rank | Percentile |
|---|---|---|
Pharmacology, Toxicology and PharmaceuticsPharmacology |
182 / 313 | 42% |
Journal Statistics
Submission Information
Submission Website:
http://mc.manuscriptcentral.com/txenRelated Articles
Ab initio quantum dynamical analysis of ultrafast nonradiative transitions via conical intersections in pyrazine
Manabu Kanno, Yuta Ito, Noriyuki Shimakura, Shiro Koseki, Hirohiko Kono
DOI: 10.1039/C4CP04807E
On the nature of hydrogen bonds to platinum(ii) – which interaction can predict their strength?
Rocío Sánchez-de-Armas, Mårten S. G. Ahlquist
DOI: 10.1039/C4CP04657A
Measurement and PC-SAFT modelling of three-phase behaviour
Iago Rodríguez-Palmeiro, Oscar Rodríguez, Ana Soto, Christoph Held
DOI: 10.1039/C4CP04336G
Molecular dynamics simulations of longer n-alkanes in silicalite: state-of-the-art models achieving close agreement with experiment
DOI: 10.1039/C4CP04898A
Analytic gradients, geometry optimization and excited state potential energy surfaces from the particle-particle random phase approximation
Du Zhang, Degao Peng, Peng Zhang
DOI: 10.1039/C4CP04109G
Magnetic and geometric anisotropy in particle-crosslinked ferrohydrogels
Lisa Roeder, Philipp Bender, Matthias Kundt, Andreas Tschöpe, Annette M. Schmidt
DOI: 10.1039/C4CP04493B
Illuminating surface atoms in nanoclusters by differential X-ray absorption spectroscopy
Charles S. Spanjers, Thomas P. Senftle, Adri C. T. van Duin, Michael J. Janik, Anatoly I. Frenkel, Robert M. Rioux
DOI: 10.1039/C4CP02146K
Reverse hydrotropy by complex formation
Kamil Wojciechowski, Thomas Gutberlet, Vikram Singh Raghuwanshi, Ann Terry
DOI: 10.1039/C4CP03835E
Electronic and optical properties of polypyridylruthenium derivatized polystyrenes: multi-level computational analysis of metallo-polymeric chromophore assemblies
Zoe Watson, Shahar Keinan
DOI: 10.1039/C4CP04043K
Buffers more than buffering agent: introducing a new class of stabilizers for the protein BSA
Bhupender S. Gupta, Mohamed Taha, Ming-Jer Lee
DOI: 10.1039/C4CP04663C
You might also like
What is Ethyl 3-cyclohexylpropanoate (CAS: 10094-36-7)?
Ethyl 3-cyclohexylpropanoate is a clear, colorless to light yellow liquid with a...
How should waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl)nicotinic acid (CAS: 34783-31-8) be handled?
Waste containing 2-(Hydroxymethyl)-5-(methoxycarbonyl)-6-methyl-4-(2-nitrophenyl...
How should waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) be handled?
Waste containing 2,4,6-Tris(pentafluoroethyl)-1,3,5-triazine (CAS: 858-46-8) sho...
What precautions should be taken when handling Chloroac-nle-oh (CAS: 56787-36-1)?
When handling Chloroac-nle-oh (CAS: 56787-36-1), it is essential to wear appropr...
What industries use Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate (CAS: 752244-05-6)?
Ethyl 6-phenylimidazo[2,1-b][1,3]thiazole-3-carboxylate is primarily used in the...
Are there alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis?
Alternatives to alpha-(2-Bromophenyl)benzylamine (CAS: 55095-15-3) in synthesis ...
How should waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) be handled?
Waste containing 2-Chloro-5-methoxypyridine (CAS: 139585-48-1) should be managed...
What industries use 1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9)?
1-(4-Methoxyphenyl)-2,5-dimethyl-1H-pyrrole (CAS: 5044-27-9) is used in various ...
Are there alternatives to 3-Bromo-5-(N-Boc)aminomethylisoxazole (CAS: 903131-45-3) in synthesis?
There are alternative reagents and compounds that can be used in the synthesis o...
What is Tungsten(IV) oxide (CAS: 12036-22-5)?
Tungsten(IV) oxide, also known as tungsten dioxide, is a chemical compound with ...










![2-{3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride (1:1) structure 2-{3-[4-(3-Chlorophenyl)-1-piperazinyl]propyl}[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one hydrochloride (1:1) structure](https://static.chemtradehub.com/structs/253/25332-39-2-496e.webp)


![1-(Hexopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl 3-phenylacrylate structure 1-(Hexopyranosyloxy)-4a,5-dihydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-7-yl 3-phenylacrylate structure](https://static.chemtradehub.com/structs/192/19210-12-9-ecae.webp)



